Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out
in the Schedule hereto:
Schedule
Product: Abraxane
Active Ingredient: Paclitaxel 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Abraxis BioScience LLC, Arizona, United States of America
Fresenius Kabi USA LLC, Illinois, United States of America
Fresenius Kabi USA LLC, New York, United States of America
Dated this 28th day of February 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).